Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Person

Jonathan Trent

Tracked across 1 events · 7 articles · First seen Apr 16, 2026 · Last active May 14, 2026

Sentiment
50
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 50
Business
Impact: Jonathan Trent, MD of the University of Miami, Sylvester Comprehensive Cancer Center, commented on the significant advancement the Phase 2 trial for STC-15 represents in sarcoma treatment.
Apr 16, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Jonathan Trent live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.